Interact CardioVasc Thorac Surg 2007;6:622. doi:10.1510/icvts.2007.155523A1 © 2007 European Association of Cardio-Thoracic Surgery
Institutional report - Cardiopulmonary bypass |
ICVTS on-line discussion A1 Reply to Kan
Bansi Koul,
Faleh Al-Rashidi,
Misha Bhat and
Leif Pierre
Cardiothoracic Surgery, University Hospital Lund, 22185 Lund, Sweden
Acute plateletpheresis and aprotinin reduces the need for bloodtransfusion following Ross operation
eResponse: Our study [1] has shown that acute intraoperative plateletpheresis (APP), harvesting platelet-rich plasma equivalent to 25% of the estimated circulating platelet count; in combination with low-dose aprotinin reduces significantly the need for perioperative transfusion of blood products in comparison to low-dose aprotinin alone in patients undergoing Ross operation. Following complex cardiac surgery under cardio-pulmonary bypass (CPB), for APP alone to be effective, what we need to investigate in a prospective manner is the magnitude of an effective APP. This question becomes more pertinent if one plans to utilise APP in patients undergoing surgery under deep hypothermia and circulatory arrest, in which aprotinin is relatively contraindicated. Till the time this question is answered, it appears that the combination of APP with aprotinin or an antifibrinolytic drug reduces the need for perioperative transfusion significantly in comparison to APP alone in patients undergoing complex cardiac surgery under CPB [2]. At present our policy is to give all patients undergoing major cardiac surgery, except those subjected to deep hypothermia and circulatory arrest, 2 million units of aprotinin directly into the CPB circuit after the patients have been re-warmed to 350 °C. This policy enables us to use deep hypothermic circulatory arrest, without hesitation, if we decide for that during on-going routine CPB.
 |
References
|
|---|
- Al-Rashidi F, Bhat M, Pierre L, Koul B. Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation. Interact CardioVasc Thorac Surg 2007; 6:618–622.[Abstract/Free Full Text]
- Stover EP, Siegel LC, Hood PA, O' Riordan GE, McKenna TR. Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery. Anesth Analg 2000; 90:509–516.[Abstract/Free Full Text]
Related Article
-
Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation
- Faleh Al-Rashidi, Misha Bhat, Leif Pierre, and Bansi Koul
Interactive CardioVascular and Thoracic Surgery 2007 6: 618-622.
[Abstract]
[Full Text]
[PDF]
|
|